HTG Molecular Diagnostics, Inc.
Hedge Funds Holdings
Last updated:
HTG Molecular Diagnostics, Inc.‘s stocks are currently a part of 8 hedge funds’ portfolios, which represents 1.05% of the total amount of its stocks outstanding. This makes up a total of 9.34K shares of HTG Molecular Diagnostics, Inc.. Compared to the previous quarter, the number fell by -43.43% or -7.17K shares fewer. As for the holding position changes, 37.5% (3) of current hedge fund investors increased the number of shares held, 25% (2) of current holders sold a part of the shares held. 1 hedge funds are new holders of HTG Molecular Diagnostics, Inc. stock in Q1 2023, it is 12.5% of total holders.
Hedge funds holding HTG Molecular Diagnostics (Q2 2018 – Q1 2023)
| Q2 2018 | 43 |
|---|---|
| Q3 2018 | 54 |
| Q4 2018 | 48 |
| Q1 2019 | 39 |
| Q2 2019 | 43 |
| Q3 2019 | 42 |
| Q4 2019 | 26 |
| Q1 2020 | 30 |
| Q2 2020 | 26 |
| Q3 2020 | 26 |
| Q4 2020 | 17 |
| Q1 2021 | 18 |
| Q2 2021 | 21 |
| Q3 2021 | 20 |
| Q4 2021 | 17 |
| Q1 2022 | 16 |
| Q2 2022 | 14 |
| Q3 2022 | 13 |
| Q4 2022 | 8 |
| Q1 2023 | 8 |
Hedge funds changes in HTG Molecular Diagnostics positions (Q2 2018 – Q1 2023)
| Q2 2018 | 13 | 14 | 6 | 9 | 1 |
|---|---|---|---|---|---|
| Q3 2018 | 20 | 14 | 11 | 9 | 0 |
| Q4 2018 | 12 | 16 | 10 | 17 | -7 |
| Q1 2019 | 3 | 12 | 14 | 11 | -1 |
| Q2 2019 | 9 | 10 | 15 | 5 | 4 |
| Q3 2019 | 10 | 12 | 10 | 11 | -1 |
| Q4 2019 | 6 | 7 | 5 | 22 | -14 |
| Q1 2020 | 7 | 9 | 7 | 1 | 6 |
| Q2 2020 | 6 | 8 | 3 | 10 | -1 |
| Q3 2020 | 4 | 9 | 4 | 5 | 4 |
| Q4 2020 | 16 | 0 | 0 | 25 | -24 |
| Q1 2021 | 5 | 7 | 2 | 4 | 0 |
| Q2 2021 | 6 | 7 | 4 | 3 | 1 |
| Q3 2021 | 5 | 3 | 4 | 5 | 3 |
| Q4 2021 | 2 | 1 | 8 | 5 | 1 |
| Q1 2022 | 4 | 4 | 3 | 5 | 0 |
| Q2 2022 | 3 | 5 | 3 | 5 | -2 |
| Q3 2022 | 0 | 3 | 6 | 1 | 3 |
| Q4 2022 | 8 | 0 | 0 | 13 | -13 |
| Q1 2023 | 1 | 3 | 2 | 0 | 2 |
Hedge funds changes in HTG Molecular Diagnostics stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 61,000 | 3,000 |
| Q4 2018 | 30,000 | 2,000 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 5,000 | 1,000 |
| Q4 2020 | 0 | 18,000 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 0 |
| Q4 2021 | 0 | 0 |
| Q1 2022 | 0 | 0 |
| Q2 2022 | 0 | 0 |
| Q3 2022 | 0 | 0 |
| Q4 2022 | 0 | 0 |
| Q1 2023 | 0 | 0 |
Top 50 hedge fund holders of HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM)
| Hedge fund | Value | Shares owned | Portfolio share |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC Jim Simons | 53K | 86.40K | 0.000% |
| BLACKROCK INC. Larry Fink | 45K | 74.19K | 0.000% |
| VIRTU FINANCIAL LLC | 44K | 72.45K | 0.004% |
| VANGUARD GROUP INC | 43K | 70.92K | 0.000% |
| GEODE CAPITAL MANAGEMENT, LLC | 28K | 47.17K | 0.000% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 17K | 27.45K | 0.000% |
| MILLENNIUM MANAGEMENT LLC Israel Englander | 15K | 23.68K | 0.000% |
| TWO SIGMA SECURITIES, LLC | 13K | 21.66K | 0.000% |
| STATE STREET CORP | 9K | 14.45K | 0.000% |
| MORGAN STANLEY | 7K | 10.61K | 0.000% |
| HIGHMARK WEALTH MANAGEMENT LLC | 4K | 6.96K | 0.003% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 3K | 4.50K | 0.000% |
| ALLWORTH FINANCIAL LP | 2K | 3.32K | 0.000% |
| CITIGROUP INC | 0 | 0 | 0.000% |